Generating inhibitors of P-glycoprotein: where to, now?

Methods in molecular biology (Clifton, N.J.)

Volumn 596, Issue , 2010, Pages 405-432

  Crowley, Emily ^a   McDevitt, Christopher A ^a   Callaghan, Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; GLYCOPROTEIN P;

ARTICLE; BINDING SITE; CHEMISTRY; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG DESIGN; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; BINDING SITES; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; P-GLYCOPROTEIN;

EID: 73949136293     PISSN: None     EISSN: 19406029     Source Type: Journal    
DOI: 10.1007/978-1-60761-416-6_18     Document Type: Article

References (0)